Genetic Polymorphisms of the TGFB1 Signal Peptide and Promoter Region: Role in Wilms Tumor Susceptibility?
- PMID: 34722128
- PMCID: PMC8532353
- DOI: 10.15586/jkcvhl.v8i4.182
Genetic Polymorphisms of the TGFB1 Signal Peptide and Promoter Region: Role in Wilms Tumor Susceptibility?
Abstract
The aim of the present study was to investigate the rs1800468 (G-800A), rs1800469 (C-509T), rs1800470 (C29T), and rs1800471 (G74C) TGFB1 genetic polymorphisms and their haplotype structures in patients with Wilms Tumor (WT) and neoplasia-free controls. The genomic DNA was extracted from 35 WT patients and 160 neoplasia-free children, and the TGFB1 polymorphisms were genotyped by polymerase chain reaction, followed by restriction fragment length polymorphism. The haplotype structures were inferred, and permutation and logistic regression tests were performed to check for differences in haplotype distribution between the control and WT individuals. Positive associations were found in the recessive model for rs1800469 T allele (OR: 8.417; 95% CI: 3.177 to 22.297; P < 0.001) and for the rs1800470 C allele (OR: 3.000; 95% CI: 1.296 to 6.944; P = 0.01). Haplotype analysis revealed a significant negative association between GCTG and WT (OR: 0.236, 95% CI: 0.105 to 0.534; P = 0.0002); by contrast, the GTTG haplotype was associated with increased risk for WT (OR: 12.0; 95% CI: 4.202 to 34.270; P < 0.001). Furthermore, rs1800469 was negatively correlated with tumor size and a trend toward a positive correlation for capsular invasion was observed in the dominant model (Tau-b: -0.43, P = 0.02 and tau-b: 0.5, P = 0.06, respectively). This is the first study with rs1800468, rs1800469, rs1800470, and rs1800471 TGFB1 polymorphisms in WT, and our results suggest that the TGFB1 promoter and signal peptide region polymorphisms may be associated with WT susceptibility and clinical presentation.
Keywords: TGFB1; Wilms tumor; genetic polymorphism; nephroblastoma; prognosis; susceptibility.
Copyright: Ishibashi CM and Amarante MK.
Figures

Similar articles
-
Transforming growth factor beta 1 (TGFβ1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis.J Cancer Res Clin Oncol. 2018 Apr;144(4):645-655. doi: 10.1007/s00432-018-2585-9. Epub 2018 Jan 23. J Cancer Res Clin Oncol. 2018. PMID: 29362917 Free PMC article.
-
Genetic variation in TGFB1 gene and risk of idiopathic recurrent pregnancy loss.Mol Hum Reprod. 2013 Jul;19(7):438-43. doi: 10.1093/molehr/gat012. Epub 2013 Feb 15. Mol Hum Reprod. 2013. PMID: 23416372
-
Transforming growth factor beta 1 polymorphisms and haplotypes associated with breast cancer susceptibility: A case-control study in Tunisian women.Tumour Biol. 2019 Aug;41(8):1010428319869096. doi: 10.1177/1010428319869096. Tumour Biol. 2019. PMID: 31405342
-
Association of Transforming Growth Factor β1 Gene Polymorphisms and Inflammatory Factor Levels with Susceptibility to Sepsis.Genet Test Mol Biomarkers. 2021 Mar;25(3):187-198. doi: 10.1089/gtmb.2020.0143. Genet Test Mol Biomarkers. 2021. PMID: 33734893
-
Large-scale population-based study shows no association between common polymorphisms of the TGFB1 gene and BMD in women.J Bone Miner Res. 2007 Feb;22(2):195-202. doi: 10.1359/jbmr.061016. J Bone Miner Res. 2007. PMID: 17059371
Cited by
-
Therapeutic potential of mangiferin in cancer: Unveiling regulatory pathways, mechanisms of action, and bioavailability enhancements - An updated review.Food Sci Nutr. 2023 Dec 20;12(3):1413-1429. doi: 10.1002/fsn3.3869. eCollection 2024 Mar. Food Sci Nutr. 2023. PMID: 38455223 Free PMC article. Review.
-
Association between NAT10 gene rs8187 G > A polymorphism and Wilms tumor susceptibility in Chinese Han children: a five-center case-control study.BMC Cancer. 2025 Mar 17;25(1):494. doi: 10.1186/s12885-025-13922-6. BMC Cancer. 2025. PMID: 40098076 Free PMC article.
References
-
- Akpa MM, Iglesias D, Chu L, Thiebaut A, Jentoft I, Hammond L, et al. . Wilms tumor suppressor, WT1, cooperates with microRNA-26a and microRNA-101 to suppress translation of the polycomb protein, EZH2, in mesenchymal stem cells. J Biol Chem. 2016;291(8):3785–95. 10.1074/jbc.M115.678029 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous